Ocular Immunology and Inflammation: Vol 31, No 6

Por um escritor misterioso
Last updated 25 setembro 2024
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Roles of biomaterials in modulating the innate immune response in ocular therapy
Ocular Immunology and Inflammation: Vol 31, No 6
Fellowship in Vitreoretinal Diseases and Surgery Department of Ophthalmology and Visual Sciences
Ocular Immunology and Inflammation: Vol 31, No 6
Development and application of the ocular immune-mediated inflammatory diseases ontology enhanced with synonyms from online patient support forum conversation - ScienceDirect
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis - ScienceDirect
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer
Ocular Immunology and Inflammation: Vol 31, No 6
Blocking Autophagy in M1 Macrophages Enhances Virus Replication and Eye Disease in Ocularly Infected Transgenic Mice
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
Table of Contents — July 19, 2022, 119 (29)
Ocular Immunology and Inflammation: Vol 31, No 6
Single-cell transcriptional profiling of murine conjunctival immune cells reveals distinct populations expressing homeostatic and regulatory genes - Mucosal Immunology
Ocular Immunology and Inflammation: Vol 31, No 6
Mucosal immunology of the ocular surface
Ocular Immunology and Inflammation: Vol 31, No 6
Relapsing Encephalomyelitis After COVID-19 Infection and Vaccination
Ocular Immunology and Inflammation: Vol 31, No 6
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy

© 2014-2024 evergreenrecruitment.co.uk. All rights reserved.